Effectiveness of Movement System Impairment(MSI) based Classification Treatment on Clinical Outcomes among Subjects with Tibiofemoral Hypomobility Syndrome: A Randomized Controlled Trial

The participants will be screened for eligibility criteria. An initial assessment of evaluating the symptoms and signs of patients with tibiofemoral hypomobility syndrome made by a judgement based on MSI classification. Once participant fulfills inclusion criteria, informed consent will be obtained, and all baseline outcome measure will be recorded. Participants will be assigned to one of two groups (Group A: Experimental group, Group B: Standard Exercise care)   using block randomization. The allocation sequence will be placed in opaque, sealed envelopes. The therapist treating the participants would open the sealed envelope and administer the treatment according to the group allocation during treatment time. A qualified therapist who unaware of the study protocol, participants group allocation will assess all outcome measures (Numeric pain rating scale, knee injury and osteoarthritis outcome score). Intervention group will receive MSI treatment based exercise. Control group will receive standarised exercise therapy. Between group comparison will be performed